Die globale Verteilung von COVID-19-Impfstoffen durch die Public Private Partnership COVAX in öffentlich-rechtlicher Perspektive (A Public Law Perspective on the Global Distribution of COVID-19 Vaccines by the Public Private Partnership COVAX)

Achenbach Jv.

Open source

DOI
10.2139/ssrn.4019960
Published
2022-02-01
Container
Not recorded
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2139/ssrn.4019960,
  title = {Die globale Verteilung von COVID-19-Impfstoffen durch die Public Private Partnership COVAX in öffentlich-rechtlicher Perspektive (A Public Law Perspective on the Global Distribution of COVID-19 Vaccines by the Public Private Partnership COVAX)},
  author = {Achenbach Jv.},
  year = {2022},
  doi = {10.2139/ssrn.4019960},
  url = {https://doi.org/10.2139/ssrn.4019960}
}

RIS

TY  - JOUR
TI  - Die globale Verteilung von COVID-19-Impfstoffen durch die Public Private Partnership COVAX in öffentlich-rechtlicher Perspektive (A Public Law Perspective on the Global Distribution of COVID-19 Vaccines by the Public Private Partnership COVAX)
AU  - Achenbach Jv.
PY  - 2022
DO  - 10.2139/ssrn.4019960
UR  - https://doi.org/10.2139/ssrn.4019960
ER  - 

APA

Jv., A. (2022). Die globale Verteilung von COVID-19-Impfstoffen durch die Public Private Partnership COVAX in öffentlich-rechtlicher Perspektive (A Public Law Perspective on the Global Distribution of COVID-19 Vaccines by the Public Private Partnership COVAX). https://doi.org/10.2139/ssrn.4019960

Source records